Physiological, pharmacological and pathological factors affecting the pharmacokinetics of calcium entry blockers.
Padrini
R
R
Department of Pharmacology, University of Padova.
Piovan
D
D
Bova
S
S
Moretto
R
R
Cargnelli
G
G
Ferrari
M
M
D000375:Aging / Q000378:metabolism; D000818:Animals; D002121:Calcium Channel Blockers / Q000493:pharmacokinetics*; D004110:Diltiazem / Q000493:pharmacokinetics; D004334:Drug Administration Schedule; D006168:Guinea Pigs; D006801:Humans; D007536:Isomerism; D008099:Liver / Q000378:metabolism; D008107:Liver Diseases / Q000378:metabolism; D008991:Monitoring, Physiologic; D009543:Nifedipine / Q000493:pharmacokinetics; D010641:Phenotype; D014700:Verapamil / Q000493:pharmacokinetics
D002121:Calcium Channel Blockers; D014700:Verapamil; D004110:Diltiazem; D009543:Nifedipine